Nanion Technologies
27.02. - 01.03.2017 | Translational Opportunities in Stem Cell Research International Conference

Venue: International Society for Stem Cell Research (ISSCR), StemBANCC and the Basel Stem Cell Network for Translational Opportunities in Stem Cell Research, Congress Center Basel, Hall 4, Messeplatz 21, 4058 Basel, Switzerland

Meet Elena Dragicevic from the headquarters in Germany.

Elena will present a poster: "ADVANCING DRUG DISCOVERY AND DISEASE MODELING: AUTOMATION AND OPTOGENETICS FOR PATCH-CLAMP AND MEA TECHNOLOGY"

Download the poster abstract here.

Go to the Conference website here.

 

06. - 07.03.2017 | Stem Cells in Drug Discovery

Venue: Wellcome Genome Campus Conference Centre, Cambridge, UK 

Meet Elena Dragicevic from the headquarters in Germany. Elena wil present a poster. Title: "All Inclusive approach" for electrophysiological high-throughput screening and drug discovery using iPS derived cardiomyocytes.

Download the poster abstract here.

Go to the Conference website here.

08.03.2017 | Stem Cell Themed Conference

Venue: Granta Park, Suite 1, Riverside 3, Great Abington, Cambridge CB21 6AD, United Kingdom 

Metrion Biosciences, Axiogenesis and Nanion Technologies will be co-hosting a stem cell themed conference and series of laboratory demonstrations.

Meet Elena Dragicevic and Sonja Stölzle-Feix from the headquarters in Germany.

Download the Conference flyer here.

The event is free to attend. Spaces are limited, please register your interest at This email address is being protected from spambots. You need JavaScript enabled to view it.  and the organizers will be in touch.

 

Preliminary program:

Symposium:

9:00 – 9:05 Welcome greetings (Andrew Southan)

9:05 – 9:35 Mohamed Kreir (Janssen): Drug-induced Seizure prediction: Rat in vitro to rat in vivo is good, but are human iPSC's better to human prediction?

9:35 – 9:50 Tristan Pritchard (Axiogenesis): t.b.a.

9:50 – 10: 20 Michela Noseda (Imperial College London): t.b.a.

10:20 – 10:50 Coffee break

10:50 – 11:10 Sonja Stölzle-Feix (Nanion): Are drug effects on multiple cardiac ion channels confirmed by impedance/EFP data from iPS-CM?

11:10 – 11:40 Matthew Bridgland Taylor (AstraZeneca): t.b.a.

11:40 – 11: 55 Said El Haou (Metrion Biosciences): In depth profiling of iPSC-CM - from electrophysiology to phenotypic assays.

12:00 – 13:00 – Lunch

Assay demonstrations: (iPSC-derived cardiomyocytes on Patchliner, Maestro and CardioExcyte 96)

13:00 – 14:00 – Demo rotation 1

14:00 – 14:30 – Mixing

14:30 – 15:30 – Demo rotation 2

15:30 – 16:00 – Mixing

16:00 – 17:00 – Demo rotation 3